Patent assignee · FR · COMPANY

CELLECTIS SA

18Patents
15Active
18Granted
47Portfolio score

Filing activity: Sep 13, 2002 → Dec 21, 2023 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7098031B2 Random integration of a polynucleotide by in vivo linearization Chemistry; Metallurgy 29 Expired
US9315788B2 Method for the generation of compact TALE-nucleases and uses thereof Chemistry; Metallurgy 8 Active
US8530214B2 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof Chemistry; Metallurgy 5 Active
US8206965B2 Hybrid and single chain meganucleases and use thereof Chemistry; Metallurgy 4 Expired
US8624000B2 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof Chemistry; Metallurgy 2 Active
US11690873B2 Universal chimeric antigen receptor T cells specific for CD22 Chemistry; Metallurgy 2 Active
US9044492B2 Method for modulating the efficiency of double-strand break-induced mutagenesis Chemistry; Metallurgy 1 Active
US11944643B2 Universal anti-CD22 chimeric antigen receptor engineered immune cells Chemistry; Metallurgy 1 Active
US9982251B2 Large volume ex vivo electroporation method Chemistry; Metallurgy 0 Expired
US10494626B2 Dynamic mixing and electroporation chamber and system Chemistry; Metallurgy 0 Active
US12133867B2 Universal anti-CD22 chimeric antigen receptor engineered immune cells Chemistry; Metallurgy 0 Active
US11555198B2 Method for making nicotiana plants with mutations in XylT and FucT alleles using rare-cutting endonucleases Chemistry; Metallurgy 0 Active
US11576317B2 Mutant Nicotiana benthamiana plant or cell with reduced XylT and FucT Chemistry; Metallurgy 0 Active
US8697395B2 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof Chemistry; Metallurgy 0 Active
US11578318B2 Large volume ex vivo electroporation method Chemistry; Metallurgy 0 Active
US8293701B2 Methods and compositions relating to a vaccine against prostate cancer Human Necessities 0 Active
US8927247B2 I-CreI derived single-chain meganuclease and uses thereof Chemistry; Metallurgy 0 Active
US11778993B2 Repeat variable diresidues for targeting nucleotides Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.